Results 161 to 170 of about 18,836 (198)
Some of the next articles are maybe not open access.

Posaconazole

Drugs of Today, 2005
Invasive fungal infections are occurring with increasing frequency secondary to medical advances in the areas of transplantation, cancer management and autoimmune diseases. Unfortunately, the currently available antifungal armamentarium does not meet the increasing needs of managing infection in these complex patient populations.
Elizabeth S, Dodds Ashley   +1 more
openaire   +4 more sources

Therapeutic Drug Monitoring of Posaconazole: An Update [PDF]

open access: yesCurrent Fungal Infection Reports, 2016
Posaconazole is a second-generation triazole agent with a potent and broad antifungal activity. In addition to the oral suspension, a delayed-release tablet and intravenous formulation with improved pharmacokinetic properties have been introduced ...
Jan-Willem Alffenaar   +2 more
exaly   +3 more sources

Safety of posaconazole

Expert Opinion on Drug Safety, 2013
The increasing number of invasive fungal infections (IFI) among immunocompromised hosts is a significant clinical issue. Diagnosis of IFI, choosing among the available antifungal drugs, and the high morbidity/mortality associated with IFI pose clinical challenges for healthcare providers.
Pauline L, Jacinto   +1 more
openaire   +2 more sources

Posaconazole

Reactions Weekly, 2022
openaire   +1 more source

Home - About - Disclaimer - Privacy